These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33143114)

  • 41. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.
    Barrett AD; Monath TP; Barban V; Niedrig M; Teuwen DE
    Vaccine; 2007 Apr; 25(15):2758-65. PubMed ID: 17368349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepato-pathological hallmarks for the surveillance of Yellow Fever in South American non-human primates.
    Passos PHO; Ramos DG; Romano AP; Cavalcante KRLJ; Miranda LHM; Coelho JMCO; Barros RC; Martins Filho AJ; Quaresma JAS; Macêdo IL; Wilson TM; Sousa DER; de Melo CB; Castro MB
    Acta Trop; 2022 Jul; 231():106468. PubMed ID: 35429458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The risk of urban yellow fever outbreaks in Brazil by dengue vectors. Aedes aegypti and Aedes albopictus].
    Mondet B; da Rosa AP; Vasconcelos PF
    Bull Soc Pathol Exot; 1996; 89(2):107-13; discussion 114. PubMed ID: 8924767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of yellow fever virus circulation in wildlife rodents from Brazil.
    de Oliveira Figueiredo P; Stoffella-Dutra AG; Costa GB; de Oliveira JS; Amaral CD; Alves PA; Filho JDA; Paz GF; Tonelli GB; Kroon EG; Drumond BP; Paglia AP; de Oliveira DB; de Souza Trindade G
    Braz J Microbiol; 2022 Jun; 53(2):647-654. PubMed ID: 35133637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Yellow Fever Susceptibility in New World Nonhuman Primates, Comparison with Humans, and Implications for Surveillance.
    de Azevedo Fernandes NCC; Guerra JM; Díaz-Delgado J; Cunha MS; Saad LD; Iglezias SD; Ressio RA; Dos Santos Cirqueira C; Kanamura CT; Jesus IP; Maeda AY; Vasami FGS; de Carvalho J; de Araújo LJT; de Souza RP; Nogueira JS; Spinola RMF; Catão-Dias JL
    Emerg Infect Dis; 2021 Jan; 27(1):47-56. PubMed ID: 33350931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yellow fever risk assessment in the Central African Republic.
    Staples JE; Diallo M; Janusz KB; Manengu C; Lewis RF; Perea W; Yactayo S; Sall AA;
    Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):608-15. PubMed ID: 24947520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental Adaptation of the Yellow Fever Virus to the Mosquito Aedes albopictus and Potential risk of urban epidemics in Brazil, South America.
    Amraoui F; Pain A; Piorkowski G; Vazeille M; Couto-Lima D; de Lamballerie X; Lourenço-de-Oliveira R; Failloux AB
    Sci Rep; 2018 Sep; 8(1):14337. PubMed ID: 30254315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re-emergence of yellow fever in the neotropics - quo vadis?
    Sacchetto L; Drumond BP; Han BA; Nogueira ML; Vasilakis N
    Emerg Top Life Sci; 2020 Dec; 4(4):399-410. PubMed ID: 33258924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019.
    Giovanetti M; de Mendonça MCL; Fonseca V; Mares-Guia MA; Fabri A; Xavier J; de Jesus JG; Gräf T; Dos Santos Rodrigues CD; Dos Santos CC; Sampaio SA; Chalhoub FLL; de Bruycker Nogueira F; Theze J; Romano APM; Ramos DG; de Abreu AL; Oliveira WK; do Carmo Said RF; de Alburque CFC; de Oliveira T; Fernandes CA; Aguiar SF; Chieppe A; Sequeira PC; Faria NR; Cunha RV; Alcantara LCJ; de Filippis AMB
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.
    Kleinert RDV; Montoya-Diaz E; Khera T; Welsch K; Tegtmeyer B; Hoehl S; Ciesek S; Brown RJP
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31627415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
    Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
    Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance for yellow Fever virus in non-human primates in southern Brazil, 2001-2011: a tool for prioritizing human populations for vaccination.
    Almeida MA; Cardoso Jda C; Dos Santos E; da Fonseca DF; Cruz LL; Faraco FJ; Bercini MA; Vettorello KC; Porto MA; Mohrdieck R; Ranieri TM; Schermann MT; Sperb AF; Paz FZ; Nunes ZM; Romano AP; Costa ZG; Gomes SL; Flannery B
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2741. PubMed ID: 24625681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human Urban Arboviruses Can Infect Wild Animals and Jump to Sylvatic Maintenance Cycles in South America.
    Figueiredo LTM
    Front Cell Infect Microbiol; 2019; 9():259. PubMed ID: 31380302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia.
    Kieffer A; Hoestlandt C; Gil-Rojas Y; Broban A; Castañeda-Cardona C; Rosselli D
    Value Health Reg Issues; 2019 Dec; 20():60-65. PubMed ID: 30974312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for multiple sylvatic transmission cycles during the 2016-2017 yellow fever virus outbreak, Brazil.
    Moreira-Soto A; Torres MC; Lima de Mendonça MC; Mares-Guia MA; Dos Santos Rodrigues CD; Fabri AA; Dos Santos CC; Machado Araújo ES; Fischer C; Ribeiro Nogueira RM; Drosten C; Sequeira PC; Drexler JF; Bispo de Filippis AM
    Clin Microbiol Infect; 2018 Sep; 24(9):1019.e1-1019.e4. PubMed ID: 29427798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.